D espite a recent decline in mortality, 1 cerebrovascular disease (stroke) remains the fifth leading cause of death in the United States and the leading preventable cause of disability.
2 Furthermore, quality of life (QOL) after stroke depends on more than retention of physical functioning and ability. 3 Psychological health and well-being are known to associate with QOL outcomes, 4 for example, an estimated 30% of stroke survivors develop depression. 5 Although poststroke depression (PSD) is a well-researched and established phenomenon, [6] [7] [8] far less is known about the development of poststroke post-traumatic stress disorder (PTSD). 9 Researchers have hypothesized that acute medical conditions such as asthma attack 10 and myocardial infarction 11 can precipitate PTSD, but PTSD specifically after a stroke has only been formally conceptualized for <2 decades. 12 Despite the relative paucity of research on poststroke PTSD, this article attempts to consolidate what is currently known: elaborating on the construct of poststroke PTSD, weighing the conflicting prevalence reports in the literature, exploring identified or hypothesized pre-morbid and post-morbid predicting factors, and summarizing promising future directions for research. Identifying gaps or conflicting findings may facilitate future studies to identify risk factors for poststroke PTSD and establish a more efficacious management strategy.
Epidemiology
Stroke is one of the leading causes of disability in adults. 2 With estimated prevalence rates of 20% to 65%, depression is a pervasive consequence of stroke that has been linked to cognitive deficits including memory, nonverbal problem solving, attention, and psychomotor speed. 13 Likewise, depressive symptoms experienced up to 12 months after hospitalization for subarachnoid hemorrhage (SAH) are tightly associated with QOL, more so than both demographic variables and hemorrhage severity.
14 But PSD is not the only mental health outcome that may follow stroke; poststroke PTSD has similarly been shown to impact mental health and QOL as well. 15 Beyond mood dysregulation, poststroke PTSD has also been associated with an increased risk of nonadherence to medication, 16 which presents a great obstacle for long-term management of cerebrovascular and psychiatric disorders.
In its most recent iteration, the DSM-V (Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition) defines PTSD as a trauma and stressor-related disorder, comprising 4 core symptomatic clusters: intrusion, avoidance, negative alterations in cognitions and mood, and alterations in arousal or reactivity. 17 This disorder, therefore, is different from PSD: whereas both contain elements of negative alterations in cognition and mood, PTSD is differentiated by the hallmark findings of intrusive thoughts and avoidance of stimuli-bearing reminders of the trauma, in addition to experiencing hyperarousal and heightened fear (see the Table for diagnostic criteria and screening measures) . Notably, despite the differences in diagnostic criteria, a recent systematic review noted that no studies examined both psychological sequelae of depression and PTSD poststroke; thus, overlap and comorbidity between these conditions have yet to be elucidated. 7 Yet, medical disorders are known to cause psychological trauma 19 (eg, congenital heart disease 20 and SAH 21 ). This is especially more common if the patient requires intensive care unit care. 22 As psychological trauma is the core, key feature around which PTSD develops, many of these inpatient conditions can lead a patient to develop PTSD. 22 Indeed, the number of cerebrovascular conditions associated with PTSD is rising: transient ischemic attack (TIA), 23 spontaneous cervical artery dissection, 18 and SAH 24 to name a few. Despite the modest increase in identifying PTSD in stroke survivors, the raw prevalence of poststroke PTSD has been difficult to identify. Studies report conflicting incidence rates: 4%, 25 10%, 12 18%, 24 30%, 23 and as high as 37%. 26 In an effort to sort through this significant variability, a meta-analysis of survivors of stroke and TIA reported that 1 out of every 4 patients experienced significant PTSD symptoms in the year after a cerebrovascular event. 27 Overall, these findings are much higher than the prevalence of PTSD in the general population, which is estimated to be 6.8%. 28 However, these results are to be interpreted with the understanding that a few studies included TIA and stroke. ; notably, recent meta-analyses have not made this distinction. 27 As the pathogenic origin of stroke affects patients differently both in severity and nature of symptoms, these subtypes may differently predispose patients to developing PTSD. The discrepancies between various studies may indicate either inconsistencies in study methodology (sample size, inclusion criteria, operationalization, or definition of PTSD) or differences in the propensity for these various conditions to give rise to PTSD. If the latter is true, then it becomes imperative for future research to outline careful inclusion and exclusion criteria and be more specific in both reporting their findings and extrapolating to various patient populations. Regardless, with prevalence findings as variable as those reported above, it is clear that the medical community could benefit from more robust methodologies to discern the prevalence of poststroke PTSD.
Predictive Factors of Poststroke PTSD
In the following section, we examine recent findings on variables that may predict poststroke PTSD development although most studies examining mental health outcomes of cerebrovascular events focus on depression. Studies tend to rely on linear modeling and correlation analysis to identify significant predictors. Here, we review demographic variables (age and sex), as well as psychological and socioeconomic variables of interest. Given that the cause of PTSD in a nonstroke population is complex, multifactorial, and irreducible, we are not surprised to find that many studies examining poststroke PTSD development report conflicting results. Nevertheless, there are a few promising trends that we discuss below, with the hope that future inquiries into these relationships can more clearly elucidate the mechanisms by which stroke can precipitate PTSD.
Age
Studies examining the impact of age on poststroke PTSD vary in demographic composition and sample size. A small study in Switzerland found no significant relationship between age and PTSD symptoms after a nonsevere stroke. 30 Another UK study on patients with stroke similarly found no correlation between age and the number or severity of PTSD symptoms at follow-up. 31 A study on patients with SAH 3 years postdischarge found that age did not significantly differ in patients with and without PTSD symptoms. 32 However, other studies conflict with these null findings. For example, in a large analysis of stroke patients in Northern Manhattan and the Bronx, the mean age of those with PTSD was 7 years lower than those without. 33 In an analysis on patients with TIA, it was found that, although age distribution did not significantly differ between subjects with or without PTSD, a logistic regression model did reveal age to be a significant protective factor against PTSD symptoms, such that older patients were less likely to develop the condition. 23 Taken in combination, these studies indicate that perhaps younger age contributes to poststroke PTSD development.
Sex
Despite being one of the most commonly investigated correlates, there is conflicting evidence as to whether sex affects the development of poststroke PTSD. It has been known for decades that women are at greater risk for PTSD than men, with a lifetime prevalence ratio of 2:1 when compared with men. 34 However, given the qualitative difference in trauma experienced between medical and nonmedical PTSD, it remains necessary to examine whether sex differences exist in poststroke development. Although a definitive consensus has not yet been reached, existing literature indicates that women may be more prone to developing poststroke PTSD than men: in a large analysis of stroke and TIA survivors, patients who exhibited symptoms consistent with PTSD were over twice as likely to be female than male. 33 In fact, another study found that, of all medical and sociodemographic variables examined in stroke survivors, only sex associated with PTSD symptoms or diagnosis on follow-up. 35 However, there are studies in which sex and poststroke PTSD are independent variables.
31

Psychological Variables
Studies examining psychological predictors of poststroke PTSD most commonly include negative cognitive appraisals, maladaptive coping, alexithymia, and avoidance. Many studies show that there is an association between dysfunctional coping strategies and the severity of PTSD symptoms. 36, 37 Negative cognitive appraisals are tainted, distorted perceptions that cause an individual to have negative feelings about an event they experience; these appraisals are intrinsic, personal qualities of cognitive styles. There is evidence that patients who have negative cognitive appraisals also have worse mental health outcomes poststroke. 38, 39 In poststroke PTSD specifically, cognitive appraisals are predictive of symptoms such that greater negative trauma appraisals resulted in more PTSD symptoms. 30 Independently, another study found a significant correlation between measures of negative cognitions about one's self and the world and the severity of PTSD symptoms after a stroke. 25 These findings illustrate that negative cognitive appraisals are a construct that have some predictive value on the development of poststroke PTSD.
Another construct that may affect poststroke PTSD are coping strategies. Maladaptive coping strategies are ways in which individuals cope with stress and adversity that are poorly adaptable and correlate with burnout, depression, and anxiety. Although few studies have specifically examined coping strategies in a stroke population, one study has shown that maladaptive coping strategies are predictive of poststroke PTSD symptoms on follow-up. 23 In addition, alexithymia, a psychological description of the difficulty or inability to convey and identify emotions, has been found to associate with poststroke PTSD as well. In a prospective study, alexithymia at baseline predicted severity of symptoms on follow-up. 40 Ultimately, the landscape of these studies is murky. Studies suffer from small sample sizes and nonuniform follow-up times. In addition, few studies examine the interplay between a myriad of psychosocial factors, instead just examining one factor at a time in different samples. It is possible that broadening the scope of the constructs included may allow researchers to sort through these relationships and identify the factors that are most predictive.
Socioeconomic Status
Previous research has examined associations between specific socioeconomic variables (income, level of education, race, etc.) and poststroke PTSD. Unfortunately, relationships have to date been difficult to elucidate. For example, lower education and unemployment status proved to predict poststroke PTSD in 1 study conducted in Harlem, New York. 33 In addition, in a study from Geneva, Switzerland, lower levels of education (<11 years) correlated with poststroke PTSD symptoms. 30 However, other studies have not shown this relationship. 25, 31, 35, 41 Furthermore, the relationship between unemployment and poststroke PTSD is potentially confounded by stroke severity, such that a more severe stroke prevents employment from being feasible and elicits a stress disorder response in patients. 33 Also, different studies have not uniformly operationalized or measured socioeconomic predictors. Income and employment were found to be significant in studies in which they were included 33 although many others did not consider them. 25, 30, 35, 41 Robust socioeconomic variables that predict poststroke PTSD have yet to fully determined.
Insurance Status
Although insurance status is not an issue in some European countries, it has been shown to affect QOL in other countries such as the United States. For the countries in which insurance status remains an issue, it is an important variable to consider with respect to poststroke PTSD. Previous research has focused on the association between insurance status and PSD, rather than poststroke PTSD, finding correlations between uninsured status and depressive symptoms. 42 However, the relationship between PTSD (and poststroke PTSD) and insurance status remains relatively unexplored, with few studies differentiating between the insurance statuses of patients pre-and poststroke. In an attempt to elucidate poststroke PTSD predictors in a population of patients in Harlem, 1 study accounted for the insurance status of patients, noting whether they had commercial insurance, Medicare, or Medicaid (this category also includes those who are uninsured) at the time of admission. 33 Medicaid (or low income) status conferred an increased risk of developing poststroke PTSD. 33 Few other studies directly relate insurance status, stroke, and PTSD. One study with indirect implications on this relationship investigated medication adherence, finding patients with poststroke PTSD to demonstrate more ambivalence toward medications than those without poststroke PTSD. 16 Given the nature of insurance-to provide compensation for medical needs-uncertainty about taking medication may result from insurance status-related
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factors. Understanding this relationship is critical for future research, as insurance status and medication nonadherence by proxy impair positive QOL outcomes.
Type of Stroke
As indicated previously, the pathogenic origin of the stroke, hemorrhagic, or ischemic may unequally predispose individuals to developing PTSD, given that symptomatic presentation and morbidities are different. Although there are no large analyses that specifically address this question, there are a few studies that examine poststroke PTSD in patients after hemorrhagic stroke, namely, SAH, to identify more specific predictors. In a prospective cohort study on patients with SAH, sleep and fatigue indices on follow-up were highly correlated with worse PTSD symptom severity. 26 A study on a similar sample found that fear, specifically about the recurrence of an SAH, was highly associated with experiencing PTSD symptoms. 43 These findings suggest that there are specific factors associated with hemorrhagic stroke associated with post-stroke PTSD; it remains to be seen whether these identified factors are unique to SAH or whether they are associated with more stroke subtypes as well.
Pathophysiology and Biological Correlates
Although there have been many discoveries made in recent years about the neural underpinnings of PTSD in the general population, 44, 45 far less is known about the biological correlates of PTSD after stroke. Understanding the effect of lesion location, or if a patient has a biological predisposition to adverse mental health outcomes, would be useful in any case. This is especially true here given the distinct medical and biological nature of poststroke PTSD when compared with nonmedical PTSD, which lacks a clear physiological precipitant. Therefore, here, we briefly review relevant findings and discuss future directions for research.
It has been demonstrated that there are replicated structural abnormalities in the cortex between patients who have PTSD. The most common macroscopic abnormality is a reduction of the volume of the ventromedial prefrontal cortex, as well as reduced hippocampal volume. 44, 46 However, it remains unclear whether the structural findings are a diathesis in the development of PTSD, or rather a consequence of experiencing stress. 47 Nevertheless, researchers have proposed that the ventromedial prefrontal cortex plays a role in suppressing attention allocation to trauma-related stimuli in healthy subjects, and attenuation of this response explains the experience of PTSD in patients. 48 Intrahemispheric lesion location in patients with stroke has been postulated to have an effect on the development of mood disorders, 49 and it is possible that the site of intracerebral bleeding might affect poststroke PTSD development. Indeed, more recent neuroimaging studies examining the effect of local lesions in trauma-exposed (nonstroke) individuals found that lesions in the amygdala or ventromedial prefrontal cortex resulted in a reduction of PTSD symptom intensity, rather than conferring increased risk. 50 These findings, although relevant here, have caveats: first, the population of patients did not involve stroke survivors, thus only indirectly addressing the question of poststroke PTSD, and the finding contradicts the hypothesis that damage to the ventromedial prefrontal cortex or amygdala would result in more severe poststroke PTSD. Unfortunately, to date, there are no studies that we are aware of that examine the impact of stroke location on the development of poststroke PTSD, and those that have attempted to characterize lesion effect on PSD have been inconclusive. 51 It is conceivable, given previous findings in nonstroke populations, that the location of intracranial bleeding and tissue infarction may shape psychological prognosis.
Beyond macroscopic findings from imaging or postmortem research, dysregulation of neuroendocrine functioning has been implicated both in PTSD and depression in a poststroke population. The hypothalamic-pituitary axis responsible for cortisol secretion at the adrenal glands has been particularly closely examined; it has been found that lower baseline levels of cortisol are linked to PTSD. 52 As Pitman et al 44 point out, the idea that a cortisol deficit plays a role in PTSD pathogenesis is corroborated with findings that abnormal glucocorticoid levels interfere with memory, learning, stress adaptation, and resilience. 53 Furthermore, a recent report on the administration of high-dose hydrocortisone after trauma exposure in a human population reported that the treatment resulted in reduced risk of PTSD development. 54 Again, these findings, although not from a stroke-specific population, indicate that deficits in cortisol may predispose an individual to develop PTSD.
Poststroke PTSD Affects QOL
Stroke impacts patients beyond the immediate physiological complications; poststroke PTSD can present longitudinal challenges to patients. Experiencing PTSD symptoms can represent a novel problem for the patient after experiencing a stroke: it has been found that fewer than half of people diagnosed with poststroke PTSD have ever experienced stress disorder symptoms in the past, 24 a result that differs from depression, in which 77% of those with PSD had a depressive episode in the past. One study on patients with SAH found that mental and physical QOL scores were predicted by poststroke PTSD scores. 26 Unfortunately, meta-analyses have not accounted for the impact of PTSD or PSD symptoms on QOL, so it is difficult to tease apart the independent effect of either disorder. 29 Finally, there are few studies examining the direct impact of PTSD symptoms specifically on QOL or physical disability in a poststroke population. Given all that we know about the importance of PSD in patient outcomes and mortality, 8 it would seem that further research on poststroke PTSD is warranted.
Management of Poststroke PTSD
Although much has been published on PTSD after acute medical events, fairly few treatment guidelines have been published on cerebrovascular-specific causes. 9 In fact, there are virtually no reports that examine the benefits of psychotherapy in a poststroke patient population having PTSD; however, a few on PSD do exist. [55] [56] [57] The most recent examination of different interventions for ischemic stroke found that, beginning 6 months after a stroke, citalopram (antidepressant) and cognitive behavioral therapy are more successful at reducing depressive symptoms than rehabilitation alone. 55 Notably, data suggest that 9 months after a stroke, cognitive behavioral therapy may be more effective than citalopram. 55 Problemsolving therapy 56 and art therapy 57 as PSD treatments have also been proposed, but without controlled empirical findings. Unfortunately, none of these therapeutic approaches for PSD have been directly compared with each other to establish a gold standard. Furthermore, it remains to be seen whether they would be beneficial for patients with poststroke PTSD, given that psychological approaches to managing other poststroke psychiatric conditions exist, perhaps similar treatments may exist for poststroke PTSD.
Although treatment approaches for PTSD exist, 58 there have not been any controlled trials examining the efficacy pharmacological or psychotherapeutic interventions for poststroke PTSD, specifically. As management of PTSD and depression differs, approaches for these psychiatric conditions should be distinguished in a poststroke population as well.
Conclusions
Ultimately, much remains unknown about poststroke PTSD. There are controversial reports on prevalence, morbidity, and predictors. Although there are promising findings on age and psychosocial variables, many studies have been hindered by differing operationalizations and methodologies. Poststroke PTSD is a common and debilitating consequence of stroke, and there is much that still needs to be learned about all the factors that contribute to its effects on patients.
